Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1466]

Using anti-PD-1 therapy pre-surgery in melanoma patients can identify those most likely to benefit

Using anti-PD-1 therapy pre-surgery in melanoma patients can identify those most likely to benefit

AACR 2018: How do melanoma cells survive drug treatment long enough to acquire drug resistance?

AACR 2018: How do melanoma cells survive drug treatment long enough to acquire drug resistance?

AACR 2018: Pembrolizumab reduced the risk for recurrence of stage 3 melanoma

AACR 2018: Pembrolizumab reduced the risk for recurrence of stage 3 melanoma

Discovery of 4 subtypes of melanoma points to new treatment approaches

Discovery of 4 subtypes of melanoma points to new treatment approaches

Double hit on melanoma unlocks barrier to immunotherapy

Double hit on melanoma unlocks barrier to immunotherapy

Novel combination therapy effective for NRAS mutant and therapy resistant melanoma

Novel combination therapy effective for NRAS mutant and therapy resistant melanoma

Last Month in Oncology with Dr. Bishal Gyawali: March 2018

Last Month in Oncology with Dr. Bishal Gyawali: March 2018

Limiting tumours' ability to hide from the immune system

Limiting tumours' ability to hide from the immune system

Last Month in Oncology with Dr. Bishal Gyawali: February 2018

Last Month in Oncology with Dr. Bishal Gyawali: February 2018

A combination of cancer immunotherapies could save more lives

A combination of cancer immunotherapies could save more lives

More from ecancer